185 related articles for article (PubMed ID: 17601493)
1. Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.
Liechti ME; Markou A
Biochem Pharmacol; 2007 Oct; 74(8):1299-307. PubMed ID: 17601493
[TBL] [Abstract][Full Text] [Related]
2. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Liechti ME; Markou A
Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
[TBL] [Abstract][Full Text] [Related]
3. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence.
Liechti ME; Lhuillier L; Kaupmann K; Markou A
J Neurosci; 2007 Aug; 27(34):9077-85. PubMed ID: 17715344
[TBL] [Abstract][Full Text] [Related]
5. The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats.
D'Souza MS; Liechti ME; Ramirez-Niño AM; Kuczenski R; Markou A
Neuropsychopharmacology; 2011 Sep; 36(10):2111-24. PubMed ID: 21654734
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys.
Justinova Z; Le Foll B; Redhi GH; Markou A; Goldberg SR
Psychopharmacology (Berl); 2016 May; 233(10):1791-800. PubMed ID: 26149611
[TBL] [Abstract][Full Text] [Related]
7. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
Pitsikas N; Markou A
Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
[TBL] [Abstract][Full Text] [Related]
8. Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer.
Baptista MA; Martin-Fardon R; Weiss F
J Neurosci; 2004 May; 24(20):4723-7. PubMed ID: 15152032
[TBL] [Abstract][Full Text] [Related]
9. Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.
Bäckström P; Hyytiä P
Eur J Pharmacol; 2005 Dec; 528(1-3):110-8. PubMed ID: 16324694
[TBL] [Abstract][Full Text] [Related]
10. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
11. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
12. Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.
Vlachou S; Paterson NE; Guery S; Kaupmann K; Froestl W; Banerjee D; Finn MG; Markou A
Eur J Pharmacol; 2011 Mar; 655(1-3):52-8. PubMed ID: 21262222
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
Bruijnzeel AW; Zislis G; Wilson C; Gold MS
Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.
Li X; D'Souza MS; Niño AM; Doherty J; Cross A; Markou A
Psychopharmacology (Berl); 2016 May; 233(10):1801-14. PubMed ID: 26873083
[TBL] [Abstract][Full Text] [Related]
16. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
Watkins SS; Stinus L; Koob GF; Markou A
J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
[TBL] [Abstract][Full Text] [Related]
17. Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence.
Aujla H; Martin-Fardon R; Weiss F
Neuropsychopharmacology; 2008 Jul; 33(8):1818-26. PubMed ID: 17895914
[TBL] [Abstract][Full Text] [Related]
18. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats.
Kawaura K; Karasawa J; Hikichi H
Pharmacol Rep; 2016 Feb; 68(1):80-4. PubMed ID: 26721357
[TBL] [Abstract][Full Text] [Related]
20. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.
Stoker AK; Olivier B; Markou A
Psychopharmacology (Berl); 2012 May; 221(2):317-27. PubMed ID: 22147259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
